An observational study in Acute Kidney Injury (Nontraumatic), sponsored by Nikola Bradic, MD. Status unknown. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-13.
Sponsored by Nikola Bradic, MD · Observational
Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI risk. Because of that, today different biomarkers are investigated to predict incidence for development AKI after cardiac surgery. This investigation will try to find potentially risk patients for developing AKI after cardiac surgery by using conventional markers (creatinine, glomerular filtration rate) in perioperative period comparing with two different biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and growth differentiation factor 15 (GDF-15) which are proven markers in patients with increased risk for AKI development.
1,595 studies on the registry are indexed under Acute Kidney Injury; 371 are open to participants now.
This study's planned enrollment of 50 is below the median of 150 across 773 observational studies indexed under Acute Kidney Injury.
Browse Acute Kidney Injury studies →This is the only study on the registry with Nikola Bradic, MD as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Patients scheduled for cardiac surgery with usage of cardiopulmonary bypass
Exclusion Criteria:
Consecutive values of neutrophil gelatinase-associated lipocalin (NGAL)
By the changing of NGAL values in consecutive measuring, predict which patients are in increased risk for development of AKI
Time frame: One year
Consecutive values of growth differentiation factor 15 (GDF-15)
By the changing of GDF-15 values in consecutive measuring, predict which patients are in increased risk for development of AKI
Time frame: One year
Consecutive values of glomerular filtration rate (GFR)
By the changing of GFR values in consecutive measuring, predict which patients are in increased risk for development of AKI
Time frame: One Year
No study locations are listed for this record.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.